» Articles » PMID: 34365576

Exosomes As Cell-derivative Carriers in the Diagnosis and Treatment of Central Nervous System Diseases

Overview
Publisher Springer
Specialty Pharmacology
Date 2021 Aug 8
PMID 34365576
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes are extracellular vesicles with the diameter ranging from 50 to 100 nm and are found in different body fluids such as blood, cerebrospinal fluid (CSF), urine and saliva. Like in case of various diseases, based on the parent cells, the content of exosomes (protein, mRNA, miRNA, DNA, lipids and metabolites) varies and thus can be utilized as potential biomarker for diagnosis and prognosis of the brain diseases. Furthermore, utilizing the natural potential exosomes to cross the blood-brain barrier and by specifically decorating it with the ligand as per the desired brain sites therapeutics can be delivered to brain parenchyma. This review article conveys the importance of exosomes and their use in the treatment and diagnosis of brain/central nervous system diseases.

Citing Articles

The theragnostic advances of exosomes in managing leukaemia.

Ghosh S, Dey A, Chakrabarti A, Bhuniya T, Indu N, Hait A J Cell Mol Med. 2024; 28(23):e70052.

PMID: 39659020 PMC: 11632122. DOI: 10.1111/jcmm.70052.


Extracellular vesicles: biological mechanisms and emerging therapeutic opportunities in neurodegenerative diseases.

Wang L, Zhang X, Yang Z, Wang B, Gong H, Zhang K Transl Neurodegener. 2024; 13(1):60.

PMID: 39643909 PMC: 11622582. DOI: 10.1186/s40035-024-00453-6.


Circular RNA landscape in extracellular vesicles from human biofluids.

Zhao J, Li Q, Hu J, Yu H, Shen Y, Lai H Genome Med. 2024; 16(1):126.

PMID: 39482783 PMC: 11526565. DOI: 10.1186/s13073-024-01400-w.


Exosomes in neuron-glia communication: A review on neurodegeneration.

Akbari-Gharalari N, Khodakarimi S, Nezhadshahmohammad F, Karimipour M, Ebrahimi-Kalan A, Wu J Bioimpacts. 2024; 14(5):30153.

PMID: 39296798 PMC: 11406431. DOI: 10.34172/bi.2023.30153.


Potential of Exosomes as Multifunctional Nanocarriers for Targeted Drug Delivery.

Al-Ani S, Lee Q, Maheswaran D, Sin Y, Loh J, Foo J Mol Biotechnol. 2024; .

PMID: 39269575 DOI: 10.1007/s12033-024-01268-6.


References
1.
Thomi G, Surbek D, Haesler V, Joerger-Messerli M, Schoeberlein A . Exosomes derived from umbilical cord mesenchymal stem cells reduce microglia-mediated neuroinflammation in perinatal brain injury. Stem Cell Res Ther. 2019; 10(1):105. PMC: 6429800. DOI: 10.1186/s13287-019-1207-z. View

2.
Kuwano N, Kato T, Mitsuhashi M, Sato-Kasai M, Shimokawa N, Hayakawa K . Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder: An exploratory pilot case-control study. J Affect Disord. 2018; 240:88-98. DOI: 10.1016/j.jad.2018.07.040. View

3.
Goetzl E, Abner E, Jicha G, Kapogiannis D, Schwartz J . Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease. FASEB J. 2017; 32(2):888-893. PMC: 5888398. DOI: 10.1096/fj.201700731R. View

4.
Gupta A, Pulliam L . Exosomes as mediators of neuroinflammation. J Neuroinflammation. 2014; 11:68. PMC: 3994210. DOI: 10.1186/1742-2094-11-68. View

5.
Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View